Compare Marga Abhinaya Abadi Tbk. (MABA) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Marga Abhinaya Abadi Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Marga Abhinaya Abadi Tbk. trades at Rp50 (market cap 768.26B), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Marga Abhinaya Abadi Tbk. is far larger — about 7.4× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| MABA | SCPI | |
|---|---|---|
Market Cap | 768.26B | 104.4B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Marga Abhinaya Abadi Tbk.
PT Marga Abhinaya Abadi Tbk (the Company) formerly PT Lintas Insana Wisesa was established based on the Deed No. 01 dated November 11, 2009 of Imam Wahyudi, SH Notary in Tangerang.
Read more on MABA →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
